Cargando…

TRAIL combinations: The new ‘trail’ for cancer therapy (Review)

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) therapy is anticipated to be one of the most effective cancer treatments. However, resistance to TRAIL therapy remains a challenge facing the development of anticancer strategies. To circumvent this problem, TRAIL combinations have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	REFAAT, ALAA, ABD-RABOU, AHMED, REDA, ASMAA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997674/ https://www.ncbi.nlm.nih.gov/pubmed/24765133 http://dx.doi.org/10.3892/ol.2014.1922

Ejemplares similares

Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest
por: Abdel Salam, Nagwa M, et al.
Publicado: (2021)

Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2021)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway
por: Zoheir, Khairy M. A., et al.
Publicado: (2022)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

The Shape Trail Test: Application of a New Variant of the Trail Making Test
por: Zhao, Qianhua, et al.
Publicado: (2013)

Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells
por: Reda, Asmaa, et al.
Publicado: (2019)

TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
por: López-Gómez, Carlos, et al.
Publicado: (2011)

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017)

A promising “TRAIL” of tanshinones for cancer therapy
por: Ho, Tsing-Fen, et al.
Publicado: (2015)

Crossed TRAILs
por: Wells, William A.
Publicado: (2002)

The white trail /
por: Dafydd, Fflur
Publicado: (2011)

The information trail
por: Berman, Carol
Publicado: (2016)

John Trail
Publicado: (1889)

Getting TRAIL back on track for cancer therapy
por: Lemke, J, et al.
Publicado: (2014)

The Combination of TRAIL and Isoflavones Enhances Apoptosis in Cancer Cells
por: Bronikowska, Joanna, et al.
Publicado: (2010)

Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines
por: Polanski, R, et al.
Publicado: (2015)

N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
por: Estornes, Yann, et al.
Publicado: (2018)

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Specific Incremental Test for Aerobic Fitness in Trail Running: IncremenTrail
por: Doucende, Grégory, et al.
Publicado: (2022)

TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
por: Mohr, Andrea, et al.
Publicado: (2015)

TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
por: Staniek, Julian, et al.
Publicado: (2019)

On the trail of a new state of matter
por: Schutz, Yves
Publicado: (2015)

On the Trail of Agent Orange
por: Tenenbaum, DJ
Publicado: (2003)

Trail Saving on Backtrack
por: Hickey, Randy, et al.
Publicado: (2020)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
por: Voss, Oliver H., et al.
Publicado: (2021)

Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL
por: Nakamura, Hiroe, et al.
Publicado: (2018)

Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
por: de Looff, Margot, et al.
Publicado: (2019)

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer
por: Ma, Sisi, et al.
Publicado: (2017)

TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
por: Dufour, Florent, et al.
Publicado: (2016)

Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2019)

Nano-TRAIL: a promising path to cancer therapy
por: Gampa, Siri Chandana, et al.
Publicado: (2023)

Tongue trail to kidney
por: Khobragade, Krunal Harishchandra, et al.
Publicado: (2014)

On the Trail of Mutagens at MIT
por: Nadis, Steve
Publicado: (1996)

On the Trail of Linked Selection
por: Josephs, Emily B., et al.
Publicado: (2016)

Project: Otorhinolaryngology Trails
por: Hueb, Prof. Dr. Marcelo
Publicado: (2015)

Trail Toward Tenecteplase
por: Srivastava, Trilochan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfafugf91n8nhl0e8af2h7qetn